This study effectively determined that BAP1, CDKN2A and NF2 alterations occur in pleural effusion-derived tumour cells at a higher frequency than what is typically seen in MM tumour samples, as well as identifying high frequency alterations for the TRAF7 and LATS2 genes. This evidence concerns the gene CDKN2A and neoplasm.